New Century Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

New Century Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$899K	Sell	2,449 -24	-1%	-$9.13K	1.27%	26
2016 Q3	$994K	Sell	2,473 -38	-2%	-$15.2K	0.87%	45
2016 Q2	$877K	Sell	2,511 -122	-5%	-$47K	0.47%	64
2016 Q1	$949K	Sell	2,633 -5,369	-67%	-$2.21M	0.45%	62
2015 Q4	$4.34M	Sell	8,002 -1	-0%	-$542	2.01%	15
2015 Q3	$3.72M	Buy	8,003 +5,309	+197%	+$2.85M	1.87%	18
2015 Q2	$1.37M	Sell	2,694 -1	-0%	-$488	0.63%	47
2015 Q1	$1.22M	Sell	2,695 -46	-2%	-$19.5K	0.56%	49
2014 Q4	$1.12M	Sell	2,741 -36	-1%	-$14.2K	0.56%	50
2014 Q3	$1M	Hold	2,777	–	–	0.52%	61
2014 Q2	$784K	Sell	2,777 -112	-4%	-$33.2K	0.43%	64
2014 Q1	$868K	Hold	2,889	–	–	0.49%	65
2013 Q4	$795K	Sell	2,889 -20	-0.7%	-$5.75K	0.48%	66
2013 Q3	$910K	Buy	2,909 +237	+9%	+$62.3K	0.62%	68
2013 Q2	$601K	Buy	+2,672	New	+$622K	0.44%	75

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

New Century Investment Management's REGN Position: Q4 2016 in Review

New Century Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.97% in Q4 2016, selling an estimated $9.13K and leaving 2,449 shares worth $899K. The position accounts for 1.27% of the portfolio, ranked #26.

New Century Investment Management first reported a position in REGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.34M in Q4 2015. 577 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

New Century Investment Management held 2,449 shares of Regeneron Pharmaceuticals worth $899K as of Q4 2016.
New Century Investment Management sold 24 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $9.13K.
Regeneron Pharmaceuticals made up 1.27% of New Century Investment Management's portfolio in Q4 2016, its #26 holding.
New Century Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
New Century Investment Management's Regeneron Pharmaceuticals position peaked at $4.34M in Q4 2015.
577 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on New Century Investment Management's 13F filing for Q4 2016, filed 25 Jan 2017.